Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Recruiting · NCT05975983 · Registry updated 2025-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 2 | 2025-11-12 | NCT05975983 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InSilico Medicine Hong Kong Limited | 8 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bogan Sleep Consultants, LLC | Columbia | United States | 1 |
| Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando | Orlando | United States | 1 |
| Florida Lung Asthma and Sleep Specialist | Celebration | United States | 1 |
| HonorHealth Research Institute | Scottsdale | United States | 36 |
| Keck School of Medicine of USC | Los Angeles | United States | 14 |
| Metroplex Pulmonary and Sleep Center | McKinney | United States | 1 |
| Research Centers of America | McKinney | United States | 1 |
| Southeastern Research Center | Winston-Salem | United States | 1 |
| Temple University Hospital-Temple Lung Center | Philadelphia | United States | 1 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| University of Oklahoma Health Sciences Center (OUHSC) | Oklahoma City | United States | 1 |
| University of Texas Southwestern Medical Center | Dallas | United States | 1 |